Treating head and neck cancer in the age of immunotherapy: a 2023 update

A Bhatia, B Burtness - Drugs, 2023 - Springer
Most patients diagnosed with head and neck squamous cell carcinoma (HNSCC) will
present with locally advanced disease, requiring multimodality therapy. While this approach …

Nasopharyngeal carcinoma

MLK Chua, JTS Wee, EP Hui, ATC Chan - The Lancet, 2016 - thelancet.com
Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from …

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

LL Tang, YP Chen, CB Chen, MY Chen… - Cancer …, 2021 - Wiley Online Library
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the
nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these …

Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline

YP Chen, N Ismaila, MLK Chua, AD Colevas… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …

Management of nasopharyngeal carcinoma: current practice and future perspective

AWM Lee, BBY Ma, WT Ng, ATC Chan - Journal of clinical oncology, 2015 - ascopubs.org
Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of …

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre …

LL Tang, CL Huang, N Zhang, W Jiang, YS Wu… - The Lancet …, 2022 - thelancet.com
Background The aim of this trial was to address whether elective ipsilateral upper-neck
irradiation (UNI) sparing the uninvolved lower neck provides similar regional relapse-free …

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

AW Lee, WT Ng, JJ Pan, SS Poh, YC Ahn… - Radiotherapy and …, 2018 - Elsevier
Purpose Target delineation in nasopharyngeal carcinoma (NPC) often proves challenging
because of the notoriously narrow therapeutic margin. High doses are needed to achieve …

Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities

X Sun, S Su, C Chen, F Han, C Zhao, W Xiao… - Radiotherapy and …, 2014 - Elsevier
Background and purpose To evaluate the long-term survival outcomes and toxicity of NPC
patients treated with intensity-modulated radiotherapy (IMRT). Materials and methods From …

[HTML][HTML] Radiation therapy in head and neck cancer

AF Alfouzan - Saudi medical journal, 2021 - ncbi.nlm.nih.gov
This review summarizes the beginning of radiotherapy, techniques of modern radiation
therapy with different types, toxicities induced by radiotherapy and their management. Head …

[HTML][HTML] Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy …

MX Zhang, J Li, GP Shen, X Zou, JJ Xu, R Jiang… - European journal of …, 2015 - Elsevier
Background To evaluate the survival benefit of intensity-modulated radiotherapy (IMRT)
compared with conventional two-dimensional radiotherapy (2D-CRT) in nasopharyngeal …